Search clinical trials for: EVONAIL® solution

Total 31686 results

Samsung Medical Center

Completed

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

Breast Cancer | Docetaxel Chemotherapy

Korea, Republic of
Institut de Cancérologie de Lorraine
Clinact

Completed

Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer. (EVONAIL)

Breast Carcinoma

France
Baxter Healthcare Corporation
Gambro Lundia AB

Completed

Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)

End Stage Renal Disease (ESRD)

France
American University of Beirut Medical Center

Completed

The Effect of Mentholyptus Drops on the Palatability of PEG-Electrolyte Solution

Colon Cancer

Lebanon
RDC Clinical Pty Ltd

Not yet recruiting

Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

Knee Joint Pain

Australia
Allergan

Completed

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Canada, United States
Massachusetts Eye and Ear Infirmary
University of Iowa; Alcon Research

Completed

Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface

Refractive Error | Myopia

United States
Bitop AG

Active, not recruiting

Multicentre Post-market Study of Ectoin® Inhalation Solution in Treatment of Asthma. (EIL-AST)

Asthma

Poland
Alcon Research

Completed

Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

Effects of Travatan Z and Xalatan on Ocular Surface Health

Ocular Hypertension | Glaucoma
Alcon Research

Completed

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®

Ocular Hypertension | Glaucoma
Alcon, a Novartis Company

Completed

OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers

Presbyopia
Boston Children's Hospital
Entrinsic Bioscience Inc.

Terminated

Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome

Short Bowel Syndrome

United States
Organ, Tissue, Regeneration, Repair and Replacement

Recruiting

Post-surgical Scars After the Use of CACIPLIQ20 (MATRISCAR)

Scars

France
University Hospital, Grenoble
Icadom; DOCAPOST; Sunrise

Completed

Sunrise® a New Medical Device to Diagnose Sleep Apnea Syndrome (SENSAPNEA)

Sleep Apnea Syndrome, Obstructive

France
Alcon Research

Completed

An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues (ID11-56)

Myopia
Bausch & Lomb Incorporated

Completed

A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses

Contact Lens Wear

United States
Biologische Heilmittel Heel GmbH

Completed

Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee (MOZArT)

Osteoarthritis, Knee

United States
Università Politecnica delle Marche

Completed

Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.

Septic Shock | Severe Sepsis

Italy
Alcon Research

Completed

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

Ocular Hypertension | Glaucoma | Open-Angle Glaucoma
Alcon Research

Completed

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
Advanced Life Solutions
Complexo Hospitalario Universitario de A Coruña

Completed

PERTRIAL - Perla® Preservation Solution

Ischemic Reperfusion Injury | Organ Transplant

Spain
CSL Behring

Completed

Haemocomplettan® P During Aortic Replacement

Aortic Aneurysm

Germany
Allergan

Completed

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

Hypotrichosis

United States
Alcon Research

Completed

Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens

Refractive Errors

United States
Allergan

Completed

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

Alopecia Areata | Eyelash Hypotrichosis

United States, Brazil
Universitair Ziekenhuis Brussel

Completed

Evaluation of Contact Phase Activation During Hemodialysis (c-phact)

End Stage Renal Disease

Belgium
Aerie Pharmaceuticals

Completed

Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Ocular Hypertension | Open Angle Glaucoma

Japan
Assistance Publique - Hôpitaux de Paris
Hoffmann-La Roche

Completed

Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis (TIDOA)

Hand Osteoarthritis

France
University Hospital, Brest

Completed

Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP)

End Stage Renal Diseases

France
Amneal Pharmaceuticals, LLC
CBCC Global Inc.; Amneal EU, Limited

Not yet recruiting

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Ocular Hypertension | Open-angle Glaucoma

United States
Allergan

Completed

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Eyelash Hypotrichosis

United States
Charite University, Berlin, Germany
WALA Heilmittel GmbH

Completed

Efficacy of Disci/Rhus Toxicodendron Comp.®, in Patients With Chronic Low Back Pain (DISCI)

Chronic Low Back Pain

Germany
Allegro Ophthalmics, LLC
Duke University; Trial Runners, LLC

Completed

A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy

Non-Proliferative Diabetic Retinopathy

United States
Austin Health

Unknown

Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation (CHLORIDE)

Shock | Critical Illness

Australia
Alcon Research

Completed

Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens

Refractive Errors

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Aldeyra Therapeutics, Inc.

Completed

An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease

Dry Eye

Canada
Alcon Research

Completed

Travoprost 3-Month Safety and Efficacy Study

Ocular Hypertension | Open-Angle Glaucoma
Hospital Sant Joan de Deu
Fundació Sant Joan de Déu; Spanish National Health System

Completed

Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation

Inflammatory Response | Multi-organ Failure

Spain
Allergan

Completed

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

Ocular Hypertension | Glaucoma, Primary Open Angle

Germany
Amneal Pharmaceuticals, LLC
CBCC Global Research

Recruiting

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Ocular Hypertension | Glaucoma, Open-Angle

United States
Mankind Pharma Limited
CBCC Global Research

Completed

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma (Glaucoma)

Glaucoma, Open-Angle

United States
Allergan

Completed

Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

Eyelashes

United States, Canada

3

Subscribe